29 September 2021
Hogan Lovells advises Eli Lilly and Company on the conclusion of a framework agreement with the EU Commission for COVID-19 treatment
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ciara Kennedy-Loest Lead | Hogan Lovells | Partner | Competition, Public & EU Law | London |
| Arne Thiermann Lead | Hogan Lovells | Partner | Strategic Operations, Agreements and Regulation (SOAR) – Life Sciences | Hamburg |
| Fabien Roy | Hogan Lovells | Partner | Medical Device and Technology | Brussels |
| Dr. Benjamin Göhl | Hogan Lovells | Associate | Strategic Operations, Agreements and Regulation (SOAR) – Life Sciences | Munich |
| Katharina Kranzfelder | Hogan Lovells | Senior associate | Business Restructuring and Insolvency | Munich |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Eli Lilly and CompanyOther
- Counterparties
- European Commission (Other)